Shared genetic architecture between schizophrenia and subcortical brain volumes implicates early neurodevelopmental processes and brain development in childhood
- PMID: 36100668
- DOI: 10.1038/s41380-022-01751-z
Shared genetic architecture between schizophrenia and subcortical brain volumes implicates early neurodevelopmental processes and brain development in childhood
Abstract
Patients with schizophrenia have consistently shown brain volumetric abnormalities, implicating both etiological and pathological processes. However, the genetic relationship between schizophrenia and brain volumetric abnormalities remains poorly understood. Here, we applied novel statistical genetic approaches (MiXeR and conjunctional false discovery rate analysis) to investigate genetic overlap with mixed effect directions using independent genome-wide association studies of schizophrenia (n = 130,644) and brain volumetric phenotypes, including subcortical brain and intracranial volumes (n = 33,735). We found brain volumetric phenotypes share substantial genetic variants (74-96%) with schizophrenia, and observed 107 distinct shared loci with sign consistency in independent samples. Genes mapped by shared loci revealed (1) significant enrichment in neurodevelopmental biological processes, (2) three co-expression clusters with peak expression at the prenatal stage, and (3) genetically imputed thalamic expression of CRHR1 and ARL17A was associated with the thalamic volume as early as in childhood. Together, our findings provide evidence of shared genetic architecture between schizophrenia and brain volumetric phenotypes and suggest that altered early neurodevelopmental processes and brain development in childhood may be involved in schizophrenia development.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Comment in
-
Schizophrenia shares genetics with brain volume alterations.Nat Rev Neurol. 2022 Nov;18(11):638. doi: 10.1038/s41582-022-00732-8. Nat Rev Neurol. 2022. PMID: 36198770 No abstract available.
References
-
- Anderson KK. Towards a public health approach to psychotic disorders. Lancet Public Health. 2019;4:e212–e213. - PubMed
-
- Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4:295–301. - PubMed
-
- Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660–9. - PubMed
-
- Carlsson M, Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull. 1990;16:425–32. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DA041174/DA/NIDA NIH HHS/United States
- U01 DA041156/DA/NIDA NIH HHS/United States
- U01 DA041106/DA/NIDA NIH HHS/United States
- U01 DA041022/DA/NIDA NIH HHS/United States
- U01 DA041148/DA/NIDA NIH HHS/United States
- U01 DA041089/DA/NIDA NIH HHS/United States
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- U01 DA041134/DA/NIDA NIH HHS/United States
- U24 DA041147/DA/NIDA NIH HHS/United States
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- U01 DA041048/DA/NIDA NIH HHS/United States
- U01 DA041120/DA/NIDA NIH HHS/United States
- U24 DA041123/DA/NIDA NIH HHS/United States
- U01 DA041028/DA/NIDA NIH HHS/United States
- U01 DA041117/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical